Trailing-twelve-month (TTM) revenue is $788.50 Million with a year-over-year growth of (11.66%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $164,682,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $158,230,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q1 FY2026Period ended 2026-03-31 | $205,416,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $260,170,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $788,498,000 |
Current P/S: $9,035,457,931 market capitalization ÷ $788,498,000 TTM revenue = 11.46x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $260.17M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:35.971Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-recurring revenues | N/A | N/A | $54M | $141M | N/A | N/A |
| Patent Sales | $600,000 | $0 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $0 | $0 | N/A | N/A | N/A | N/A |
| CHINA | $63M | $118M | $104M |
$788.50M
$788.50 Million
(11.66%)
vs. $892.57M a year ago (TTM)
+17.75%
5 Year compound annual growth rate
1 Year
(11.66%)
3 Year
+13.74%
5 Year
+17.75%
10 Year
+7.13%
15 Year
+5.86%
20 Year
+2.99%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $834.01M | ($34.50M) | (3.97%) |
| 2024 | $868.52M | +$318.93M | +58.03% |
| 2023 | $549.59M | +$91.79M | +20.05% |
| 2022 | $457.79M | +$32.38M | +7.61% |
| 2021 | $425.41M | +$66.42M | +18.50% |
| 2020 |
TTM Growth
(11.66%)
3-Year CAGR
+13.74%
5-Year CAGR
+17.75%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:35.971Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Recurring Revenues | N/A | N/A | $404M | $408M | $408M | N/A |
|---|
| Revenue - Other | N/A | N/A | N/A | N/A | N/A | $529,000 |
|---|
| Revenues | N/A | N/A | N/A | N/A | N/A | $834M |
|---|
| Technology Solutions | $12M | $5M | N/A | N/A | N/A | N/A |
|---|
| $380M |
| $309M |
| Europe | N/A | N/A | N/A | $2M | $7M | $3M |
|---|
| FRANCE | $8M | N/A | N/A | N/A | N/A | N/A |
|---|
| JAPAN | $24M | $25M | $22M | $11M | $7M | $7M |
|---|
| KOREA, REPUBLIC OF | $112M | $87M | $90M | $82M | $266M | $263M |
|---|
| Other Europe | $7M | $16M | $11M | N/A | N/A | N/A |
|---|
| SWEDEN | $8M | N/A | N/A | N/A | N/A | N/A |
|---|
| TAIWAN | N/A | N/A | $12M | $9M | $10M | $12M |
|---|
| TAIWAN, PROVINCE OF CHINA | $10M | $11M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $128M | $169M | $220M | $186M | $199M | $239M |
|---|
| $358.99M |
| +$40.07M |
| +12.56% |
| 2019 | $318.92M | +$11.52M | +3.75% |
| 2018 | $307.40M | ($225.53M) | (42.32%) |
| 2017 | $532.94M | ($132.92M) | (19.96%) |
| 2016 | $665.85M | +$224.42M | +50.84% |
